共 43 条
[1]
Yao JC(2008)One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the US J Clin Oncol 26 3063-3072
[2]
Hassan M(2008)Neuroendocrine tumor epidemiology: contrasting Norway and North America Cancer 113 2655-2664
[3]
Phan A(2010)Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan J Gastroenterol 45 234-243
[4]
Hauso O(2014)Recommendations for management of patients with neuroendocrine liver metastases Lancet Oncol 15 e8-e21
[5]
Gustafsson BI(1980)Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma N Engl J Med 303 1189-1194
[6]
Kidd M(1992)Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma N Engl J Med 326 519-523
[7]
Ito T(1998)Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma Am J Clin Oncol 21 36-38
[8]
Sasano H(1988)Prospective study of chemotherapy in patients with metstatic gastrinoma Gastroenterology 94 1326-1334
[9]
Tanaka M(1990)Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors Cancer 65 1883-1890
[10]
Frilling A(1999)Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma Cancer 86 944-948